home / stock / axdx / axdx articles
Accelerate Diagnostics (NASDAQ: AXDX) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. Thi...
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share c...
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shares are trading lower by 38% to $1.00 during Friday’s session after the company priced an under...
Accelerate Diagnostics Inc (NASDAQ:AXDX) shares are trading lower by 23.2% to $2.84 Tuesday morning after the company announced the initiation of a...
News, Short Squeeze, Breakout and More Instantly...
Accelerate Diagnostics Inc. Company Name:
AXDX Stock Symbol:
NASDAQ Market:
Accelerate Diagnostics Inc. Website:
Accelerate Diagnostics (NASDAQ: AXDX) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. Thi...
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results PR Newswire TUCSON, Ariz. , May 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 3...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...